Vaccine Safety & Efficacy

Antibody viability alludes to the capacity of immunizations to achieve the expected advantageous impacts on inoculated people in a characterized populace under perfect states of utilization. Antibody related hazard is the likelihood of an unfriendly or undesirable result happening and the seriousness of the subsequent damage to the strength of inoculated people in a characterized populace following vaccination with an immunization under perfect states of utilization.


  • Decreases in disease risks and increased attention on vaccine risks.
  • Factors Influencing Vaccine efficacy
  • Factors Influencing Vaccine efficacy
  • Higher standard of safety is expected of vaccines
  • Patient and Public acceptance and perceptions
  • Post marketing surveillance of Vaccines
  • Public confidence in vaccine safety is critical
  • Vaccine safety communication
  • Vaccine Safety Monitoring and Vaccine Pharmacovigilance
  • Vaccines generally healthy (vs. ill for drugs)

Related Conference of Vaccine Safety & Efficacy

October 30-31, 2020

32nd Annual Congress on Immunology and Vaccinations

Vancouver, Canada

Vaccine Safety & Efficacy Conference Speakers

Recommended Sessions

Related Journals

Are you interested in